STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

AGIO AGIOS PHARMACEUTICALS StockScouter® Report

5

StockScouter® Score

AGIOS PHARMACEUTICALS, a mid cap growth company in the healthcare sector, is expected to perform in line with the market over the next six months with slightly less than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • The 50-day moving average for AGIO is significantly above its 200-day moving average. Positive
  • Shares are under accumulation by financial institutions. Marginally positive for large companies like AGIO

 

Concerns

  • The enterprise value-to-sales ratio is much higher than the average for comparably-sized companies in the StockScouter universe. Very Negative
  • One or more analysts has modestly decreased quarterly earnings estimates for AGIO. Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that mid cap stocks will be out of favor, growth stocks will be out of favor, and healthcare stocks will be out of favor.

Expected Risk/Return

Progress: 40% done.
Progress: 60% done.
Low
High

Core Model Grades

C
D
F
C

Previous Ratings

5
4
2